This combination of the 12 tissue salts helps promote overall health and general well-being by replenishing essential minerals.* *These claims have not been reviewed by the Food and Drug Administration. They are based on traditional homeopathic practice.
Children from 2 to 5 years: Crush 2 tablets and dissolve in water 3 times daily, or as directed by a healthcare professional. Adults and children over 5 years: Chew 2 tablets 3 times daily, or as directed by a healthcare professional. • Do not use more than directed. • Do not take with food.
Store at room temperature. Do not use if cap seal is broken or missing.
Calcarea fluorica, Calcarea phosphorica, Calcarea sulphurica, Ferrum phosphoricum, Kali muriaticum, Kali phosphoricum, Kali sulphuricum, Magnesia phosphorica, Natrum muriaticum, Natrum phosphoricum, Natrum sulphuricum, Silicea 12X
...........................................Overall health, general well-being
The letters 'HPUS' indicate that the components in this product are officially monographed in the Homoeopathic Pharmacopoeia of the United States.
This combination of the 12 tissue salts helps promote overall health and general well-being by replenishing essential minerals.*
*These claims have not been reviewed by the Food and Drug Administration. They are based on traditional homeopathic practice.
Stop use and ask a doctor if symptoms persist for more than 7 days or worsen.
As with any drug, ask a doctor before use if pregnant or nursing.
Keep this and all medications out of the reach of children.
In case of emergency or accidental overdose, contact a medical professional or a Poison Control Center immediately.
Children from 2 to 5 years: Crush 2 tablets and dissolve in water 3 times daily, or as directed by a healthcare professional.
Adults and children over 5 years: Chew 2 tablets 3 times daily, or as directed by a healthcare professional.
• Do not use more than directed.
• Do not take with food.
Store at room temperature.
Do not use if cap seal is broken or missing.
Lactose, magnesium stearate.
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 60512-8036-5 | 2025-12-27 | C162847 | 48780-1 | 9d75b9d0-22e7-f424-e053-dadaa90a57ce | DRUGS FACTS |
| 60512-8036-6 | 2025-12-27 | C162847 | 48780-1 | 9d75b9d0-22e7-f424-e053-dadaa90a57ce | DRUGS FACTS |
| 60512-8036-5 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-22e7-f424-e053-dadaa90a57ce | DRUGS FACTS |
| 60512-8036-6 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-22e7-f424-e053-dadaa90a57ce | DRUGS FACTS |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 60512-8036 | DIAMITE (CALCAREA FLUORICA, CALCAREA PHOSPHORICA, CALCAREA SULPHURICA, FERRUM PHOSPHORICUM, KALI MURIATICUM, KALI PHOSPHORICUM, KALI SULPHURICUM, MAGNESIA PHOSPHORICA, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, NATRUM SULPHURICUM, SILICEA) TABLET, CHEWABLE [HOMEOLAB USA INC] | 1 | Legacy NDC | 20140403_5ebab98a-8dfd-459d-a8db-eec40fe5ba2c.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CALCIUM FLUORIDE | ACTIVE INGREDIENT | O3B55K4YKI | 1 | |
| CALCIUM PHOSPHATE | ACTIVE INGREDIENT | 97Z1WI3NDX | 1 | |
| CALCIUM SULFATE | ACTIVE INGREDIENT | WAT0DDB505 | 1 | |
| FERRUM PHOSPHORICUM | ACTIVE INGREDIENT | 91GQH8I5F7 | 1 | |
| MAGNESIUM PHOSPHATE, DIBASIC | ACTIVE INGREDIENT | A1Y870209Z | 1 | |
| POTASSIUM CHLORIDE | ACTIVE INGREDIENT | 660YQ98I10 | 1 | |
| POTASSIUM PHOSPHATE, DIBASIC | ACTIVE INGREDIENT | CI71S98N1Z | 1 | |
| POTASSIUM SULFATE | ACTIVE INGREDIENT | 1K573LC5TV | 1 | |
| SILICON DIOXIDE | ACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| SODIUM CHLORIDE | ACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| SODIUM PHOSPHATE, DIBASIC | ACTIVE INGREDIENT | GR686LBA74 | 1 | |
| SODIUM SULFATE | ACTIVE INGREDIENT | 0YPR65R21J | 1 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | 1 | |
| CHLORIDE ION | ACTIVE MOIETY | Q32ZN48698 | 1 | |
| COLLOIDAL SILICON DIOXIDE | ACTIVE MOIETY | ETJ7Z6XBU4 | 1 | |
| FERROSOFERRIC PHOSPHATE | ACTIVE MOIETY | 91GQH8I5F7 | 1 | |
| FLUORIDE ION | ACTIVE MOIETY | Q80VPU408O | 1 | |
| MAGNESIUM PHOSPHATE, DIBASIC | ACTIVE MOIETY | A1Y870209Z | 1 | |
| PHOSPHATE ION | ACTIVE MOIETY | NK08V8K8HR | 1 | |
| POTASSIUM CATION | ACTIVE MOIETY | 295O53K152 | 1 | |
| SODIUM SULFATE ANHYDROUS | ACTIVE MOIETY | 36KCS0R750 | 1 | |
| SULFATE ION | ACTIVE MOIETY | 7IS9N8KPMG | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 60512-8036 | 60512-8036-5, 60512-8036-6 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CALCIUM FLUORIDE | O3B55K4YKI | ACTIB |
| CALCIUM PHOSPHATE | 97Z1WI3NDX | ACTIB |
| CALCIUM SULFATE | WAT0DDB505 | ACTIB |
| FERRUM PHOSPHORICUM | 91GQH8I5F7 | ACTIB |
| POTASSIUM CHLORIDE | 660YQ98I10 | ACTIB |
| POTASSIUM PHOSPHATE, DIBASIC | CI71S98N1Z | ACTIB |
| POTASSIUM SULFATE | 1K573LC5TV | ACTIB |
| MAGNESIUM PHOSPHATE, DIBASIC | A1Y870209Z | ACTIB |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
| SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | ACTIB |
| SODIUM SULFATE | 0YPR65R21J | ACTIB |
| SILICON DIOXIDE | ETJ7Z6XBU4 | ACTIB |
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 47 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | WAFER / ORAL | 66 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, EXTENDED RELEASE / ORAL | 173 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | CAPSULE, COATED PELLETS / ORAL | 265 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, FOR SUSPENSION / ORAL | 2794 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | RING / VAGINAL | 2 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET / BUCCAL | 43 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 9 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | INHALANT / ORAL | 0.08 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | SYSTEM / INTRAVITREAL | 0.02 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CREAM / TOPICAL | NA | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET / ORAL | 4384 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE / ORAL | 256.4 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, SUGAR COATED / ORAL | NA | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | INJECTION / INTRAVENOUS | 900 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, EXTENDED RELEASE / ORAL | 117 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 46e740cf-e36d-8249-e063-6294a90aa02f | 5ebab98a-8dfd-459d-a8db-eec40fe5ba2c | 2025-12-26 | Warnings | 5ebab98a-8dfd-459d-a8db-eec40fe5ba2c |
Adverse event summaries are temporarily unavailable. Other product information remains available.